|
|
|
|
| LEADER |
02052nma a2200301 u 4500 |
| 001 |
EB002195547 |
| 003 |
EBX01000000000000001333012 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
240202 ||| eng |
| 020 |
|
|
|a 1179
|
| 020 |
|
|
|a 9789533076157
|
| 020 |
|
|
|a 9789535143888
|
| 100 |
1 |
|
|a Kapetanovic, Izet M.
|
| 245 |
0 |
0 |
|a Drug Discovery and Development
|h Elektronische Ressource
|b Present and Future
|
| 260 |
|
|
|b IntechOpen
|c 2011
|
| 300 |
|
|
|a 1 electronic resource (542 p.)
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Pharmacology / bicssc
|
| 700 |
1 |
|
|a Kapetanovic, Izet M.
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/3.0/
|
| 024 |
8 |
|
|a 10.5772/1179
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/129087
|z DOAB: description of the publication
|
| 856 |
4 |
0 |
|u https://mts.intechopen.com/storage/books/671/authors_book/authors_book.pdf
|7 0
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615
|
| 520 |
|
|
|a Drug discovery and development process aims to make available medications that are safe and effective in improving the length and quality of life and relieving pain and suffering. However, the process is very complex, time consuming, resource intensive, requiring multi-disciplinary expertise and innovative approaches. There is a growing urgency to identify and develop more effective, efficient, and expedient ways to bring safe and effective products to the market. The drug discovery and development process relies on the utilization of relevant and robust tools, methods, models, and validated biomarkers that are predictive of clinical effects in terms of diagnosis, prevention, therapy, and prognosis. There is a growing emphasis on translational research, a bidirectional bench to the bedside approach, in an effort to improve the process efficiency and the need for further innovations. The authors in the book discuss the current and evolving state of drug discovery and development.
|